These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 5037135)

  • 21. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 22. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia].
    Serrano PA; Irigoyen M
    Prensa Med Mex; 1972; 37(7):246-50. PubMed ID: 4646433
    [No Abstract]   [Full Text] [Related]  

  • 23. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
    van der Drift JH
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073
    [No Abstract]   [Full Text] [Related]  

  • 25. [L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
    Brockmann AW
    Ther Ggw; 1970 Nov; 109(11):1590-3. PubMed ID: 5486128
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of L-dopa therapy in Parkinson's disease.
    Mones RJ; Elizan TS; Siegel GJ
    N Y State J Med; 1970 Sep; 70(18):2309-18. PubMed ID: 5272106
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU; Hoel RL; Lassman FM
    Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of Parkinson's disease with levodopa].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract]   [Full Text] [Related]  

  • 30. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H
    Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385
    [No Abstract]   [Full Text] [Related]  

  • 31. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L; Martin JD; Gutrecht JA
    W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660
    [No Abstract]   [Full Text] [Related]  

  • 32. [Levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G; Cannella M
    Minerva Med; 1969 Nov; 60(95):4733-45. PubMed ID: 5357313
    [No Abstract]   [Full Text] [Related]  

  • 33. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I
    J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
    [No Abstract]   [Full Text] [Related]  

  • 34. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 35. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
    Mazza C; Buffatti PF; Bazzan A; Lion P
    Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease].
    Buscaino GA; Campanella G
    Sist Nerv; 1970; 22(2):82-91. PubMed ID: 5504561
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M
    Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease.
    Van Woert MH
    Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 40. Parkinson's disease: L-dopa treatment and handwriting area.
    Knopp W; Paulson G; Allen JN; Smeltzer D; Brown FD; Kose W
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):115-25. PubMed ID: 4985489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.